// App-Quantinova.ai

: A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD

Researchers

Presenter

  • Dirk-Jan Slebos

Principal Investigators

  • Pallav Shah

  • Felix Herth

  • Christophe Pison

  • Christian Schumann

  • Romain Kessler

  • Peter Bonta

  • Wolfgang Gesierich

  • Ralph-Harto Hubner

  • Kaid Darwiche

  • Bernd Lamprecht

  • Thierry Perez

  • Dirk Skowasch

  • Gaetan Deslee

  • Arschang Valipour

Medical Centers

  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, Harefield, United Kingdom

  • Thoraxklinik-Heidelberg gGmbh, Heidelberg, Germany

  • CHU de Grenoble Clinique Universitaire de Pneumologie, Université Grenoble Alpes, Grenoble, France

  • Klinikverbund Kempten-Oberallgaeu GmbH, Kempten, Germany

  • CHU Stasbourg, Strasbourg, France

  • Academic Medical Center, Amsterdam, Netherlands

  • Asklepios-Fachkliniken Munchen-Gauting, Gauting, Germany

  • Brustzentrum Charite-Universitatsmedizin, Berlin, Germany

  • Ruhrlandklinik – West German Lung Center, Essen, Germany

  • Kepler Universitätsklinikum Linz, Linz, Austria

  • CHU de Lille - Hopital Calmette, Lille, France

  • Universitatsklinikum Bonn, Bonn, Germany

  • Department of Pulmonary Medicine, INSERM UMRS 903, CHU of Reims, Reims, France

  • Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Otto-Wagner-Spital, Austria,

Locations

  • Netherlands

  • United Kingdom

  • Germany

  • France

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Influenza

  • Dyspnea

  • Chronic obstructive pulmonary disease

Biomarkers

  • Bone Morphogenetic Protein 1

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • NCT02058459

Sponsors

  • N/A

Result

  • N/A